Digital Health Technologies for Alzheimer’s Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort

These findings provide clinicians and researchers a landscape overview describing the range of technologies for assessing Alzheimer’s disease and related dementias. A living library of technologies is presented for the clinical and research communities which will keep findings up-to-date as the field develops.

About this resource

Clinical Trials, Digital Measures Best Practices

New FREE course! DiMe is excited to share Google's Generative AI for Healthcare course with our community. Take this brief survey and begin the course specifically designed for medical professionals, administrators, and researchers who want to leverage AI in healthcare settings!

Work with DiMe on an upcoming project

Digital Health Technologies for Alzheimer’s Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort

About this resource

Related resources that might interest you

Simulator of study power for Parkinson’s Disease trials

Value of novel digital endpoints in late-stage trials

Advancing digital biomarkers to accelerate Parkinson’s disease drug development

Digital Endpoints Business Case Template

Multimodal digital health technologies (DHTs) allow for more efficient and less costly recruitment and reduced patient burden with decentralized clinical trials

Digital Endpoints ROI Calculator

Enhancing clinical insights: De-risking traditional outcome measures in Bellerophon Therapeutics REBUILD study

Digital Endpoints Value Framework

Estimating the benefits of digital and plasma-based pre-screening in Alzheimer’s Disease trial recruitment

Multimodal digital measures demonstrate greater responsiveness and sensitivity to disease progression and treatment effects than traditional clinical scales

Accelerated trial setup & operations: A case study in Cystic Fibrosis to illustrate the ROI of improved data availability

Advancing nano-rare disease treatment with Syde technology in clinical trials

Driving innovation in Huntington’s Disease by tracking progression through at-home digital measurements

High-Quality Evidence for DHTs — A Checklist

DiMe Case Study: Caption Health – Stage C

DiMe Case Study: Caption Health – Stage B

DiMe Case Study: Caption Health – Stage A

DiMe Case Study: Applied VR – Stage C

DiMe Case Study: Applied VR – Stage B

DiMe Case Study: Applied VR – Stage A